Drug Approval | April 24, 2023
Zydus receives final approval from the USFDA for Icosapent Ethyl Capsules
Icosapent Ethyl Capsules are indicated as an adjunct to diet to reduce triglyceride levels
Icosapent Ethyl Capsules are indicated as an adjunct to diet to reduce triglyceride levels
With a focus on optimizing patient experience with next-generation oral dosage forms, the US facility complements the cutting-edge research activities of Roquette’s existing pharma innovation centers in France and Singapore
Bayer reported the highest market capitalization growth of 23.1% during Q1 2023
Metoprolol is used with or without other medications to treat high blood pressure (hypertension).
Roflumilast reduces inflammation in the lungs that leads to chronic obstructive pulmonary disease (COPD)
Estradiol Transdermal System USP, 0.014 mg/day (weekly) had annual sales of USD 1.9 mn in the United States
Isoproterenol hydrochloride injection is indicated to improve hemodynamic status in patients in distributive shock and shock due to reduced cardiac output
Tavaborole Topical Solution, 5% had annual sales of US $3.1 million in the United States
Azithromycin Tablets USP, 500 mg had annual sales of US $20 million in the United States
Galvus has the potential to contribute significantly to Cipla’s portfolio in the diabetes care continuum space with reported sales of Rs. 268 crore
Subscribe To Our Newsletter & Stay Updated
